Siemens Healthineers announced today its Innovance Antithrombin assay has achieved FDA clearance for a new claim allowing it to be used as a companion diagnostic test for people receiving treatment ...

Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward ...

Today, Benzinga's options scanner spotted 10 uncommon options trades for Vertex Pharmaceuticals. This isn't normal. The overall sentiment of these big-money traders is split between 40% bullish ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Well thanks very much, everyone, for joining us for our next session with Vertex. My name is Dave Risinger ... where you can be off insulin and have normal blood sugar is like a dream that ...

Rep. Melanie Stansbury (D-N.M.) said during an interview that her “This is not normal” sign she held up near President Trump right before his Tuesday night speech to Congress was an “SOS to ...

This configuration maintained therapeutic peak doses while reducing the cumulative dose to adjacent normal tissues by approximately 25%. Conversely, for large (>8 cm), radioresistant tumors, our data ...

Journavx works differently than other available medications, and its developer, the biotechnology juggernaut Vertex Pharmaceuticals, has positioned it as an important, non-opioid option for pain ...

It read, “This is NOT Normal,” in black ink. The sign was held up by Rep. Melanie Stansbury, a Democrat representing New Mexico’s 1st District in the House of Representatives, which covers ...

New Mexico Rep Melanie Stansbury held up a ‘This is Not Normal’ sign beside Trump at the Congress address on Tuesday. A Republican later snatched it from her. President Donald Trump arrives ...